{
    "code": 0,
    "data": [
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Post Quarterly Financial Results conference call with investors / analyst",
            "news_id": "1e3da1f0-507b-486a-8546-7431d1e34972",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebdc13cb-482b-4c38-83de-1b7f1e166d6a.pdf",
            "news_date": "2025-11-13 18:59:09",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "d80a2aae-a625-4b5a-913c-e2b9e3da0575",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2874803-e241-4563-a280-50b13858696c.pdf",
            "news_date": "2025-11-07 19:43:08",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results Q2 FY 2025-26",
            "news_id": "607fdf1f-3e8b-46a6-8c5a-b56bb51f256d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e94e952-be35-4092-b775-7b3ece9ecce0.pdf",
            "news_date": "2025-11-07 17:52:33",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended 30-Sep-25",
            "news_body": "Results for quarter and half year ended 30-Sep-25",
            "news_id": "2bc3b0d0-df07-4dae-97ee-86c0da3249e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=259a8ec4-5486-4fff-b996-c50cbb37b964.pdf",
            "news_date": "2025-11-07 17:45:39",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call",
            "news_id": "c025f1b4-854a-4323-92be-141d67ec055d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c68ae7d-da12-4018-b0d7-901d89a709ad.pdf",
            "news_date": "2025-07-31 19:19:47",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June 2025",
            "news_id": "76083aaf-550c-427e-a200-2aff53534779",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce2a2380-22dc-4cfd-a707-f7eec3b15cfd.pdf",
            "news_date": "2025-07-28 19:39:27",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30-Jun-25",
            "news_id": "401c126c-8d77-412f-93c0-e28bfe9dc64a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f40893d7-5b78-43c0-b37c-50d1a127a763.pdf",
            "news_date": "2025-07-28 16:13:13",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter Ended 30-Jun-25",
            "news_body": "Results for quarter ended 30-Jun-25",
            "news_id": "d8f91692-93f8-4f90-aed8-74ac987aaf16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3499cf77-9c07-48a2-90f7-79c0f6a48c47.pdf",
            "news_date": "2025-07-28 16:04:17",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "60cab576-d031-4f53-ad71-60c8347d5d35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6314da61-f7f2-42a3-a461-607c3a8f44ad.pdf",
            "news_date": "2025-06-30 13:18:36",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call",
            "news_id": "2923b3a9-4a7e-49fc-80f8-f45d905aaf27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb1d6559-1989-41bc-94c7-564eddae7ee8.pdf",
            "news_date": "2025-05-23 22:34:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March 2025",
            "news_id": "42ffc965-a931-4bb4-917d-e3defaada4de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e31fd468-d11f-4370-835d-1a6eaea5755d.pdf",
            "news_date": "2025-05-20 19:46:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "d91ac46c-3826-45f6-8ddb-1ddfec6e79a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09f70655-a2f4-4b63-8191-9e0d2855cbce.pdf",
            "news_date": "2025-05-20 17:24:03",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q4 And Year Ended 31-03-2025.",
            "news_body": "Results",
            "news_id": "ce2b4733-b298-450b-b46b-136ca365fb8c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bd444ce-1a01-4b87-bc05-ba0818d8ba67.pdf",
            "news_date": "2025-05-20 17:19:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q4 And Year Ended 31-03-2025.",
            "news_body": "Results",
            "news_id": "a1f6208f-fa5c-4896-bf35-bf64c7758736",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fee6381-8bc2-4f61-a825-ebdef58b7439.pdf",
            "news_date": "2025-05-20 17:18:36",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December 2024",
            "news_id": "dabbc168-3058-448d-b0eb-a01252ad5b34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcab31f7-0c14-4010-87d9-26f9c7e6497d.pdf",
            "news_date": "2025-01-31 12:21:52",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results Q3 FY 2024-25.",
            "news_id": "897992a1-f4ec-4c2d-bccd-3738cadf755e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645825e0-582d-4814-9a5a-801fc99b4425.pdf",
            "news_date": "2025-01-24 17:03:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q3 FY 2024-25.",
            "news_body": "Results Q3 FY 2024-25",
            "news_id": "13d70500-f8b6-4569-a213-792860c2aa97",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a199b25-0d02-4052-962c-07d2b7253658.pdf",
            "news_date": "2025-01-24 16:45:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "73cb0afc-28a3-4a7e-8b45-38a6c704f94f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361f13b1-b2a6-421c-a368-19b26e108150.pdf",
            "news_date": "2024-10-30 17:25:11",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2024.",
            "news_id": "c44ede70-0806-4274-90db-99392b2984b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1405eb60-bba8-46f9-9018-8b33b6ff6021.pdf",
            "news_date": "2024-10-25 19:17:05",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results Q2 FY 2024-25.",
            "news_id": "23c9433c-67ab-4ac4-ba9b-71542d90b1d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f39a280c-aac0-4ed9-bb13-d91f8fe6c9df.pdf",
            "news_date": "2024-10-25 17:29:17",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q2 FY 2024-25",
            "news_body": "Results Q2 FY 2024-25.",
            "news_id": "fec52751-7376-4026-8812-4be0ad58a01d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=670cce05-2558-40a7-8be0-98247cddf8b4.pdf",
            "news_date": "2024-10-25 17:18:18",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024",
            "news_id": "4b614904-87f1-4fcb-ad1b-c79ab356fa39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=222507ea-9b52-4e0d-80a7-83707abd39d9.pdf",
            "news_date": "2024-07-29 16:15:13",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024",
            "news_id": "a3f4e854-f998-4ac0-8c7e-9a333daaf39f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ba1732-b394-4b51-85b5-676dffcb5ef2.pdf",
            "news_date": "2024-07-23 20:39:52",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation.",
            "news_id": "68c26b63-c478-458b-b41e-d5f6b008e3db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa02d9f7-5285-4cc8-83e4-d7e079c4d054.pdf",
            "news_date": "2024-07-23 17:29:47",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results",
            "news_body": "Results Q1 FY 2024-25.",
            "news_id": "8d4bf8bc-8d29-4df9-ae24-f6b045535d18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f88c25d5-ebec-45d3-b778-c4be3d9b4ab4.pdf",
            "news_date": "2024-07-23 17:20:51",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2024",
            "news_id": "ec003492-2c1a-46c5-8c2c-25dffe132fd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e64c694c-2f62-47e1-8af0-9e16ffe40f50.pdf",
            "news_date": "2024-05-30 12:54:03",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our letter dated 10-May-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2024, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31032024.mp3",
            "news_id": "edc4c3c7-90af-4ec2-a09e-d20979434e2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dece7aa-80ad-4bb4-a212-ce50e19c54b0.pdf",
            "news_date": "2024-05-24 20:14:45",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "dcacd2ee-e37f-4e30-957a-8da42b5416e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a717b30c-f348-44c7-9f3a-cad05e04b26a.pdf",
            "news_date": "2024-05-24 17:54:04",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results",
            "news_body": "Results",
            "news_id": "53d0af19-a5d8-40d7-a36a-2994b6984841",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3054957f-ff78-4bf3-9d1d-7b9126367fde.pdf",
            "news_date": "2024-05-24 17:48:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Analysts / Investor on Financial Results for the quarter and nine months ended 31st December, 2023",
            "news_id": "5bdc7bfc-83a0-40fb-906c-592a1523f59d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7762fe1b-da9d-435a-8b80-f6286b6c31a9.pdf",
            "news_date": "2024-02-07 12:20:27",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Con-Call With Analyst / Investor On Financial Result For Quarter And Nine Months Ended 31.12.2023",
            "news_body": "Audio recording",
            "news_id": "adf9e939-f5cb-4fa5-a6c6-12155b08cc77",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ebffe4-7736-4517-8758-ab139c75c1fb.pdf",
            "news_date": "2024-02-02 18:17:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "4738c8c9-3f84-45e6-b3dd-2eeb1dffe1e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cf60f33-090d-4f23-9a53-429f7217bbd0.pdf",
            "news_date": "2024-02-02 14:04:20",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result - Q3 2023-24",
            "news_body": "Result",
            "news_id": "792f58e7-bcf4-4cb7-9944-30c1ae432ead",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=900f497f-1ac0-4ab2-8551-31279d7c502a.pdf",
            "news_date": "2024-02-02 13:53:23",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2023",
            "news_id": "e2c257ee-1b3d-42fb-83a9-e17b5658c8f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27188d3a-20e5-42ba-a9fb-7bdc4a234de0.pdf",
            "news_date": "2023-10-26 09:53:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "28329a4f-1e92-4a41-95cc-1f548d26d05e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9e74868-f4c2-46f0-8357-29eec8f647b6.pdf",
            "news_date": "2023-10-23 18:02:21",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Half Year Ended 30-Sep-23",
            "news_body": "Financial results for quarter and half year ended 30-sep-23",
            "news_id": "bfad3ad7-e067-45ac-8f65-0b5870d73520",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d215bae-7c86-433c-8ddc-7feec8aa1624.pdf",
            "news_date": "2023-10-23 17:49:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / investors on financial results for the quarter ended 30th June, 2023 attached.",
            "news_id": "0cf11c12-42a7-4332-b8cd-cfca0d7139bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e064d44-b544-4898-86f7-136da0da704c.pdf",
            "news_date": "2023-08-11 17:41:54",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2023",
            "news_body": "Audio Recording of Conference call with Analysts /Investors on Financial Results for the quarter ended 30th June, 2023 is attached",
            "news_id": "773ad838-e5fa-4fb6-bf1c-5de89944864d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf516e89-0edc-48e7-88a8-f3e191b8fb62.pdf",
            "news_date": "2023-08-07 20:26:43",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analyst on unaudited consolidated financial result for quarter ended 30.06.2023",
            "news_id": "40fab8e3-1775-4863-94b8-7686f7d3364b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ea28e7d-ae7a-4f44-a2d3-d4cb39c25a42.pdf",
            "news_date": "2023-08-07 16:59:51",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Financial Results For Quarter Ended 30Th June, 2023",
            "news_body": "Submission / Intimation u/r 30 of SEBI (LODR) Regulation, 2015 - Financial Result for quarter ended 30th June, 2023",
            "news_id": "7949d4c6-5f47-491d-b957-384a54bee14d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72481cdb-868b-45c8-a3b6-d981cc897fd4.pdf",
            "news_date": "2023-08-07 16:40:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2023, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Earnings_Call_Transcript_May_30_2023.pdf",
            "news_id": "f9166b7d-eb98-43e5-9b93-3bb0ec37c13d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a036f42-3871-4953-819e-be809aeecaa2.pdf",
            "news_date": "2023-06-03 13:48:28",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Audited Financial Results For The Quarter And Year Ended 31St March, 2023",
            "news_body": "In continuation to our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2023, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31032023.mp3",
            "news_id": "cb76a353-c3a2-4b7b-aa33-9a9237ab43c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63b36ae7-02fb-4c88-87e9-50a4cd333339.pdf",
            "news_date": "2023-05-30 19:58:37",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2023",
            "news_id": "1a4f5883-250e-4b2b-b4f6-1225b4871385",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c993e1f5-4975-444a-92b4-507ae1bb2fe6.pdf",
            "news_date": "2023-05-30 17:49:34",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)",
            "news_body": "Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, (Listing Regulations)",
            "news_id": "2b7ae93a-33da-4b72-b33b-b97a0d5c1d96",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b730e3f-9b43-4213-bc19-7e7e827fd605.pdf",
            "news_date": "2023-05-30 16:56:11",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December, 2022",
            "news_id": "7d48e2a7-4c27-40dc-b775-ea2eb8b781c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad249fac-d0f8-498c-b333-bc4aff8d26fd.pdf",
            "news_date": "2023-02-01 17:49:29",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter And Nine Months Ended 31St December, 2022",
            "news_body": "In continuation of our letter dated 12-Jan-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and nine months ended 31st December, 2022, has been placed on the Company's website athttps://www.torrentpharma.com/pdf/investors/Audio_Recording31122022.mp3",
            "news_id": "84eddf94-9646-46bd-89a7-d089cfc99e3e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea213b90-ed26-41cf-b8a1-967a9479479a.pdf",
            "news_date": "2023-01-25 19:54:35",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2022",
            "news_id": "a402514f-38da-44c2-a298-a674c02a280e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fab33659-9711-4d55-b08e-080d5fad8e38.pdf",
            "news_date": "2023-01-25 17:13:30",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And<BR> Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and<BR> Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_id": "2edd93fa-0822-46ef-8805-c2f4efbc7dd0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4062f649-ed4b-4442-b458-dd793f15401d.pdf",
            "news_date": "2023-01-25 16:40:45",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "9537556f-50cd-4ff0-b2d6-0f05aad7697c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5703c9fc-4087-4bb1-8d72-93c251e7435f.pdf",
            "news_date": "2023-01-25 16:37:37",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2022",
            "news_id": "f750b26e-4bb2-4787-8bbf-be4c24b1b56f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcb20c10-412e-4205-b6ab-be870f8cbcca.pdf",
            "news_date": "2022-10-28 19:26:21",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and half year ended 30th September, 2022, has been placed on the Company's website athttps://www.torrentpharma.com/pdf/investors/Audio_Recording30092022.mp3",
            "news_id": "bf23313b-ede1-4b03-96ad-0f68314f2b52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d77f09e7-1e73-4bab-adef-7c7abb7cb1af.pdf",
            "news_date": "2022-10-21 20:28:11",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "e71116b8-b2b3-47ff-9aa7-0da8551da54a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60101817-3a91-46ad-801c-4badebfe7446.pdf",
            "news_date": "2022-10-21 20:18:37",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "dd233317-06d3-4ad2-b41d-a340cbb25213",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecd0a71e-d220-46f4-bc37-7a70b1162da2.pdf",
            "news_date": "2022-10-21 18:09:03",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2022",
            "news_id": "cc507872-8918-4164-affd-21aeab803abf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1a8eac7-2285-4a71-8ecc-8cf8e40089e0.pdf",
            "news_date": "2022-10-21 18:01:12",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "20de75aa-751f-4ee0-8fe9-81f3bf8b7035",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a66c5c0-04d3-4c66-a60e-f5d5a76bf746.pdf",
            "news_date": "2022-10-21 17:56:13",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on acquisition of Curatio Health Care (I) Private Limited",
            "news_id": "8ef9839f-21f0-480f-a876-77387229c598",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dee30566-673a-4d11-b4ec-c550be8ba1ba.pdf",
            "news_date": "2022-09-27 15:41:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2022",
            "news_id": "769f1412-f65e-45aa-b761-4ecf39c79c3d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4823ab49-a818-4a1d-b1f8-7b862487672c.pdf",
            "news_date": "2022-08-05 17:45:04",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2022",
            "news_body": "In continuation of our letter dated 21-Jul-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 30th June, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording30062022.mp3",
            "news_id": "a9fc0db8-ae8b-4ea7-b637-8f8d7ccf7a95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1807fcd1-7111-4e1e-a3b1-a2184d69b16a.pdf",
            "news_date": "2022-07-30 12:02:22",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30th June, 2022",
            "news_id": "43fc8928-2db0-476a-9c88-4c1ca9e0b22b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84e38bc3-c46b-4db8-90dc-393c08d50f53.pdf",
            "news_date": "2022-07-29 18:21:40",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Submission/ Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure<BR> Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Submission/ Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure<BR> Requirements) Regulations, 2015 (Listing Regulations)",
            "news_id": "854d3b08-7332-4dc1-9461-417a5f7b3485",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bee4833-977d-41c3-a2f1-5392ccf959fe.pdf",
            "news_date": "2022-07-29 18:10:22",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission/ Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Submission/ Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_id": "a81c35e0-0f26-45b6-bd3a-2b5a22b5bc03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ed4c860-8472-4e2f-a474-179eb3981f59.pdf",
            "news_date": "2022-07-29 18:04:51",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2022",
            "news_id": "5a95682c-3744-4e70-aafc-bf5035240b37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52fae571-64dc-4b87-9201-bceb12fd6e59.pdf",
            "news_date": "2022-05-30 17:39:31",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call Wit''1 Analysts / Investors On Audited Financial Results For The Quarter And Year Ended 31St March, 2022",
            "news_body": "In continuation of our letter dated 20-May-22 and pm''suant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirem??nts) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2022, has been placed on the Company''s website athttps://torrentpharma.com/pdf/investors/Audio_Recording31032022.mp3",
            "news_id": "0d4b2205-ba65-42d1-b6cd-1762486c97a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16496280-9561-4909-acee-eb231f7a67fe.pdf",
            "news_date": "2022-05-25 21:15:48",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As .Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the disclosure of Related Paity Transactions for the half year ended on 3 l-Mar-22",
            "news_id": "7596ea03-f7b5-4a41-9858-b44432672ee8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd1c98d3-d409-45d2-b9d5-412cec5238c4.pdf",
            "news_date": "2022-05-25 19:07:24",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2022",
            "news_id": "adec4c15-54ae-48c1-9dc0-45a94d7bfab0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e75a416-cb3c-4454-b5f5-2345af4e20d8.pdf",
            "news_date": "2022-05-25 18:12:52",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI<BR> (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)",
            "news_body": "Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, (Listing Regulations)",
            "news_id": "c17f6b2e-4d17-4366-ba6a-56303e7209f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1810a218-626b-453d-98be-aacf2927f257.pdf",
            "news_date": "2022-05-25 17:56:15",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI<BR> (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)",
            "news_body": "Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI<BR> (Listing Obligations and Disclosure Requirements), 2015, (Listing Regulations)<BR>",
            "news_id": "fc93f364-75b4-4d23-8385-092ed807b690",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bac43a7b-86d0-4a95-b38c-10e0b5b2813b.pdf",
            "news_date": "2022-05-25 17:50:44",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "5cd97afe-085c-402d-a8d7-c45222d67391",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1a8b149-0395-4282-a0b9-65104500e795.pdf",
            "news_date": "2022-01-25 17:58:22",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, (''Listing Regulations'')",
            "news_body": "We would like to inform that the Board has at its meeting held today approved, inter-alia, the following:<BR> <BR> 1) Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with the limited review report of the Company for the quarter and nine months ended on 31st December, 2021. The said financial results are enclosed herewith.<BR> <BR> In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and nine months ended on                                            31st December, 2021. Both Standalone and Consolidated Financial Results will be available at Company's website www.torrentpharma.com.<BR> <BR> A Press Release on Financial Results which is being submitted to the media is also enclosed herewith.<BR> <BR> <BR>",
            "news_id": "b700dbd7-f9e5-4897-8087-9df96fe0fad1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dc9b4c2-6a1b-44a0-81f0-aaa27392c1a8.pdf",
            "news_date": "2022-01-25 17:54:38",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As Per Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the Related Party Transactions on a consolidated basis for the half year ended on 30-Sep-21.<BR> <BR> Kindly take note of the above.<BR>",
            "news_id": "03ba65bd-252b-417a-adea-caecf08e7b38",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc000a06-2acd-4ff2-98d8-a33c59aa179d.pdf",
            "news_date": "2021-10-26 19:33:30",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "b5952f02-51ea-4e72-be3a-af8c630daf35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85110b94-5a79-4c4c-a51b-b066b99aa0e8.pdf",
            "news_date": "2021-10-26 18:09:25",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "b6e8122c-ab1d-40bb-b533-cbe31c9ab227",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=553fc145-397f-4337-847b-a2e9fb206bbe.pdf",
            "news_date": "2021-10-26 18:00:26",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations'')",
            "news_body": "Outcome of Board Meeting dated 26-Oct-2021",
            "news_id": "02dffa13-d2e4-4226-bf2d-3933709a78a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4e94c6b-d0d9-44af-9523-4db5332f606f.pdf",
            "news_date": "2021-10-26 17:48:58",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The presentation on unaudited Consolidated Financial Results for the quarter ended 30th June, 2021 to be made to analysts is enclosed for your records.",
            "news_id": "dbdd2610-8bf1-44e6-9f9d-4b86c57e3104",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=187abfb1-dc45-4bea-bc47-9ec17cae457e.pdf",
            "news_date": "2021-07-27 17:28:33",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission / Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_body": "Outcome of Board Meeting dated 27-Jul-2021",
            "news_id": "b57179d4-4b7c-45ad-b827-0a81e1a7af46",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a403a56b-e7ab-4a3a-a977-3f70675f6ee0.pdf",
            "news_date": "2021-07-27 17:00:54",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance As Per Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the Related Party Transactions on a consolidated basis for the half year ended on 31-Mar-21.<BR> <BR> Kindly take note of the above.",
            "news_id": "bce63021-6f89-40b9-9110-685bbebd84de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2f45bc0-d0c9-41d1-96f7-9af95c99f8ab.pdf",
            "news_date": "2021-06-07 19:25:47",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2021",
            "news_id": "6dea0689-3eac-46a5-bc08-72c4907284fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2d38719-b67b-4956-99bd-aa47f6122573.pdf",
            "news_date": "2021-05-18 16:41:38",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "TORNTPHARM",
            "disp": "Torrent Pharmaceuticals",
            "bse_code": 500420,
            "isin": "INE685A01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Outcome of Board Meeting dated 18-May-2021.",
            "news_id": "9266b387-6ca1-431d-b3a8-5bcd848a519d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=912f1395-5fe5-4ca4-b3f9-8d273be2f838.pdf",
            "news_date": "2021-05-18 16:00:02",
            "seo": "torrent-pharmaceuticals-ltd",
            "ltp": 4056.7,
            "ch": -22.90000000000009,
            "pch": -0.561329542111974,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3518,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}